Cleared Traditional

K120375 - MED-RX PATIENT DELIVERY SET

K120375 is an FDA 510(k) clearance for MED-RX PATIENT DELIVERY SET, manufactured by Benlan, Inc.. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 143-day FDA review.

K120375 · Benlan, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2012
Decision
143d
Days
Class 2
Risk

K120375 is an FDA 510(k) clearance for the MED-RX PATIENT DELIVERY SET. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Benlan, Inc. (Oakville, CA). The FDA issued a Cleared decision on June 28, 2012 after a review of 143 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Benlan, Inc. devices

FDA 510(k) Submission Details - K120375

510(k) Number K120375 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 06, 2012
Decision Date June 28, 2012
Days to Decision 143 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
14d slower than avg
Panel avg: 129d · This submission: 143d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 513
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K120375.
NIPRO SAFE TOUCH HUBER INFUSION SET
K113470 · Nipro Medical Corporation · Oct 2012
FLOWEASE [SUBCUTANEOUS] INFUSION SET
K121092 · Baxter Healthcare Corp · Jun 2012
INTERLINK SYSTEM EXTENSION SET WITH CONTROL-A-FLO-REGULATORY CLEARLINK SYSTEM EXTENSION SET WITH CONTROL-A-FLO-REGULATOR
K121634 · Baxter Healthcare Corporation · Jun 2012
PRIMARY SYMBIQ SET, DITAL MICROBORE TUBING, 0.2 MICRON FILTER, NON-DEHP
K121032 · Hospira, Inc. · Jun 2012
LIFESHIELD VISION INFUSION SET WITH PRE-PIERCED RESEAL
K113683 · Hospira, Inc. · Jan 2012
CYTOGUARD(TM) CLOSED LUER CONNECTOR
K112636 · B.Braun Medical, Inc. · Nov 2011